About NBR“Nightly Business Report produced by CNBC” (NBR) is an award-winning and highly-respected nightly business news program that airs on public television. Television’s longest-running evening business news broadcast, “NBR” features in-depth coverage and analysis of the biggest financial news stories of the day and access to some of the world’s top business leaders and policy makers.
- Here's how much Thanksgiving food $50 buys you at Acme, Aldi, Trader Joe's, Walmart and Whole Foods
- Former Amazon recruiters share insider tips on how to land a job there
- Trump to discuss Khashoggi murder with Sec of State Pompeo, CIA
- Beyond Stan Lee: Big decisions for Marvel superhero stories and films in the future
- The way to prevent World War III: Avoid delusions about China and US leadership
NBR on TwitterMy Tweets
Subscribe to RSS
Facing a national shortage of EpiPens, the Food and Drug Administration is extending the expiration dates of certain lots of the life-saving allergy drug by four months.
The life-saving allergy medicine has had manufacturing disruptions since May, but allergy sufferers and caregivers may find it especially hard to find now, as parents try to stock up to send their kids back to school.
While nearly two-thirds of large employers still contract with a dedicated pharmacy benefit management firm to handle their drug costs, they’ve lost faith with the PBM rebate model, a new survey finds.
Rep. Francis Rooney, a Republican, just signed on to the FAIR Drug Pricing Act, a bill that requires basic transparency for pharmaceutical companies that drastically spike the price of a drug.
The drug, dubbed BAN2401, slowed declines associated with Alzheimer’s disease by 30 percent at its highest dose in the trial, compared with placebo, after 18 months.
Meg Tirrell reports on what could come next for Johnson & Johnson after a jury hit the company with a $4.7B fine after more than 20 women alleged the company’s baby powder caused their ovarian cancer.
Johnson & Johnson lead attorney Bart Williams says talc-based products have been proven safe by the “best scientists in America.”
CVS and Aetna shares rose following a report that said the Department of Justice won’t challenge their merger deal. Meg Tirrell looks at what a combination of the two companies would look like.
Starting in August, Juul will introduce 3 percent nicotine pods for its mint and Virginia tobacco flavors.
Pfizer announced on Tuesday it would postpone drug price hikes after an “extensive” conversation between the company’s CEO and President Donald Trump.
Meg Tirrell reports on Dr. Atul Gawande’s first day as chief executive for Berkshire Hathaway, Amazon and J.P. Morgan’s new health care venture.
Washington has been accused of backing the interests of infant formula-makers over health advice.
Concierge medicine and other fee-based primary care practices make up less than 10 percent of physician practices.
New diet-based approaches to diabetes prevention and treatment include fresh-food prescriptions and ketogenic diets rather than drugs alone. Spending on drugs reached $53 billion last year, with mixed results.
Say hello to the health savings account. It’s your next pot of retirement dollars. How to get the most out of your account.